ArticleBMC endocrine disorders2026
Biochemical profiles and precipitating factors of diabetic ketoacidosis among type 1 and type 2 diabetes patients: a retrospective analysis from Syria.
Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetic ketoacidosis (DKA) is a life-threatening metabolic emergency characterized by hyperglycemia, ketosis, and acidosis due to insulin deficiency and counterregulatory hormone imbalances. Its prevalence is notably higher in the Arab world than in Western regions. Understanding biochemical differences between type 1 and type 2 diabetes patients with DKA is essential for individualized treatment strategies. This study examines the biochemical profiles and precipitating factors of DKA in Syrian patients, assessing differences between initial and recurrent episodes amid local healthcare challenges.
methodsThis retrospective study has ethical approval from Damascus University and Damascus Hospital, allowing access to patient charts. The study included individuals diagnosed with diabetic ketoacidosis (DKA) and admitted to Damascus Hospital. Of 997 patients, 464 charts were excluded due to missing data or uncertain diagnoses. Patients were classified into first-time and recurrent DKA, with only initial episodes considered for analysis. Diagnosis criteria varied by age group, ensuring standardized classification. Laboratory tests were performed exclusively in the hospital's central lab. Extracted variables included demographic details, hospitalization duration, diabetes type, precipitating factors, and biochemical markers.
resultsThe study analyzed 533 hospital admissions for diabetic ketoacidosis (DKA), with 263 (49.3%) being first episodes. Among these, 126 patients (47.9%) had type 1 diabetes, and 71 (26.9%) were diagnosed with diabetes after their first DKA episode. Type 2 diabetes patients exhibited higher in-hospital mortality (16.0% vs. 4.3%, p < 0.001) and longer hospital stays. Significant biochemical differences were observed between types, particularly in pH, bicarbonate, and creatinine levels. Insulin omission and unknown precipitating factors were common, especially in recurrent DKA cases.
conclusionsIn conclusion, DKA as the first presentation of diabetes is prevalent among Syrian patients. Type 1 patients were more acidotic, but their admission was shorter, probably due to comorbidities among type 2 patients. Unknown factors and insulin omission are the most prevalent triggers of DKA, especially among patients with recurrent episodes. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.